Federico Scognamiglio ๐ฎ๐น๐ช๐บ๐
@fedeloscogna
๐ก Fellow at Padua University hospital in statistics jointly with @AIRC_it.
๐ Medics with Africa member @Cuamm
โ๏ธ Contributing writer at @CS_ItaliaCanada
ID: 3164466663
https://www.linkedin.com/in/federico-scognamiglio/ 13-04-2015 15:28:52
115 Tweet
73 Followers
698 Following
Biomarkers and #AI can bring significant added value, with these also decentralized trials, syntetic arms and adaptive designs. Together they can help increase patient centricity and optimize development of new therapies especially for rare diseases. drugtargetreview.com/article/148499โฆ
Boston Children's study find that #AI devices labeled for use in children are very rare. Of those, the intresting element is that only the 19% of them reported development using pediatric datasets. The rest were validated using only adult data. answers.childrenshospital.org/ai-medical-devโฆ